Click here to get “The Truth Behind Kelly Osbourne’s Weight Loss Journey in 2025
“from the official website (Special Discount Code Applied)
Related articles
Diet With Keto Gummies. Barbra Streisand clarifies Ozempic query to Melissa McCarthy: ‘Wanted to pay her a compliment’
Barbra Streisand, the iconic entertainer known for her legendary performances in "Funny Girl" and "A Star Is Born," found herself at the center of social media buzz after a seemingly innocuous comment on Melissa McCarthy’s Instagram post sparked controversy. McCarthy had shared glamorous photos from her appearance at the Center Theatre Group’s annual gala alongside choreographer Matthew Bourne. While McCarthy’s post garnered praise from Hollywood peers, Streisand’s comment raised eyebrows.
In a now-deleted comment, Streisand asked McCarthy if she had taken Ozempic, a popular weight-loss medication, seemingly implying a connection between McCarthy’s appearance and the medication. However, Streisand later clarified that her intention was simply to compliment McCarthy’s look and express admiration for her talent. She explained that she had seen McCarthy’s photo while browsing Instagram and wanted to extend her regards, unaware of the broader audience her comment would reach.
The incident quickly sparked debate on social media, with some criticizing Streisand’s comment as inappropriate, while others defended her, suggesting she may have mistaken the public post for a private message. McCarthy, for her part, gracefully shrugged off the incident, expressing her admiration for Streisand in a brief encounter with TMZ.
This incident sheds light on the complexities of social media interactions and the unintended consequences of public comments. It also underscores the importance of clarity and context in online communication, especially for public figures like Streisand and McCarthy.
Keto Acv Gummies 500 Mg. Back to Where It All Began: Announcing Mayo Clinic’s Ketogenic Diet Study for Bipolar Disorder
Over a century ago, the term “ketogenic diet” was first coined at Mayo Clinic. Now, ketogenic therapy is returning to this historic institution —this time, as a potential treatment for bipolar disorder.
Today we are excited to announce a collaboration between Baszucki Group and Mayo Clinic to launch a new pilot study investigating how a ketogenic diet affects both mental health and cardiovascular health in individuals with bipolar disorder.
In this conversation, Dr. Kirk Nylen, Managing Director of Neuroscience at Baszucki Group, joins us to discuss the significance of this study, how it builds on past research, why Mayo Clinic’s involvement is a major step forward, and what it could mean for the future of mental health care.
? *Key Highlights:*
✅ The history of the ketogenic diet at Mayo Clinic
✅ How this study is assessing both psychiatric and cardiometabolic outcomes
✅ The role of implementation to bring this research to clinical practice
✅ What this could mean for future treatment options
We eagerly await the results of this pilot study, as they aim pave the way for the development of a new precision nutrition clinical service at Mayo Clinic.
*Read more about this exciting announcement:* https://www.businesswire.com/news/home/20250228253531/en/Precision-Nutrition-Takes-Center-Stage-in-New-Ketogenic-Therapy-Trial-and-Service
#KetogenicDiet #MentalHealth #BipolarDisorder #MetabolicPsychiatry #MayoClinic
*Expert Featured:*
Dr. Kirk Nylen, PhD
Managing Director of Neuroscience at Baszucki Group
*CMEs Mentioned:*
_Managing Major Mental Illness with Dietary Change: The New Science of Hope_
– https://www.mycme.com/courses/managing-major-mental-illness-with-dietary-change-9616
_Brain Energy: The Metabolic Theory of Mental Illness_
– https://www.mycme.com/courses/brain-energy-the-metabolic-theory-of-mental-illness-9615
Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.
Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/
*About us:*
Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.
Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.
*Timestamps:*
0:00 – Introduction to the Mayo Clinic study looking at ketogenic interventions for bipolar disorder with an eye on cardiovascular risk. Introduction to Dr. Kirk Nylen and his work at Baszucki Group.
3:49 – What is the background of the Mayo Clinic study for bipolar? What are they studying and what are future plans?
5:53 – How does the study goals compare to other bipolar studies that have been done?
7:18 – How are the cardiovascular measures of the study unique to other bipolar studies?
9:01 – How do we scale ketogenic treatments if the trial is successful?
10:58 – How can patients enroll in the study?
